How Much Did Apeiron Synthesis Raise?
Funding & Key Investors

Apeiron Synthesis has solidified its position in the advanced chemical manufacturing sector, securing a significant capital injection to accelerate its industrial-scale operations. The company, which specializes in high-efficiency catalysis, has reached a total valuation milestone represented by $4.8M. This latest infusion of capital, totaling $4.8M, marks a pivotal moment in the firm's trajectory as it transitions from a research-heavy entity to a commercial powerhouse capable of meeting global demand for complex synthetic tools.

The strategic backing underscores the growing investor confidence in the company's proprietary olefin metathesis platform. By securing this financing, Apeiron Synthesis is well-positioned to address the persistent challenges within the chemical industry, specifically the need for more sustainable and scalable production methodologies for intricate molecular structures.

What is Apeiron Synthesis?

Apeiron Synthesis
Business ServicesResearch & DevelopmentChemicals & Related Products

Apeiron Synthesis operates at the intersection of deep technology and industrial chemistry. The company has engineered a highly efficient and scalable olefin metathesis catalysis platform, a critical technology for the synthesis of complex chemical structures. By providing these advanced synthetic tools, Apeiron enables manufacturers to optimize production processes, reduce waste, and access new chemical pathways that were previously cost-prohibitive or technically unfeasible. Their market position is defined by a commitment to bridging the gap between academic research and large-scale industrial application, serving as a vital link in the global chemical supply chain.

How much funding has Apeiron Synthesis raised?

Apeiron Synthesis has raised a total of $4.8M across 1 funding round:

2022

Unspecified

$4.8M

Unspecified (2022): $4.8M with participation from APER Ventures and Adamed

Key Investors in Apeiron Synthesis

APER Ventures

APER Ventures is an investment firm focused on deep technology, seeking to support innovative companies in Central and Eastern Europe by bridging the gap between research and commercial products.

Adamed

Adamed is a major international pharmaceutical innovator with a robust portfolio of over 200 patents, focusing on global expansion and strategic research partnerships.

What's next for Apeiron Synthesis?

With this major strategic investment, Apeiron Synthesis is expected to prioritize the expansion of its manufacturing capacity and the commercial deployment of its catalysis solutions across international markets. The firm is likely to focus on scaling its operations to meet the increasing demand for specialized chemical synthesis, particularly in the pharmaceutical and materials science sectors. As the company moves into this next phase of growth, the focus will shift toward operational excellence and the further refinement of its intellectual property portfolio to maintain a competitive edge in the global chemical landscape. The infusion of capital provides the necessary runway to solidify its market leadership and drive long-term value for its stakeholders.

See full Apeiron Synthesis company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesSoftware TestingProject Management
Business ServicesProject Management
Business ServicesField Service ManagementConsumer ServicesLandscape Services
Business ServicesCommercial PrintingGraphics

Frequently Asked Questions Regarding Apeiron Synthesis Financial Insights

What are the most recent funding rounds that Apeiron Synthesis has completed, and what were the funding rounds?
Apeiron Synthesis has recently completed 1 funding rounds: Unspecified on Dec 21, 2022.
What is the total amount of funding Apeiron Synthesis has raised to date?
Apeiron Synthesis has raised a total of $4.8M in funding to date.
How many funding rounds has Apeiron Synthesis completed?
Apeiron Synthesis has completed 1 funding rounds.
How much funding did Apeiron Synthesis raise in its most recent funding round?
Apeiron Synthesis raised $4.8M in its most recent funding round.
Who are the lead investors in Apeiron Synthesis's latest funding round?
The lead investor in Apeiron Synthesis's latest funding round was APER Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Apeiron Synthesis's history?
The largest funding round in Apeiron Synthesis's history was $4.8M.
See more information about Apeiron Synthesis